secwatch.observer — SEC 8-K summary
======================================

Issuer:     Climb Bio, Inc. (CLYM)
CIK:        0001768446
Form:       8-K
Filed at:   2025-12-11T23:59:59+00:00
Accession:  0001193125-25-315108
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Climb Bio exchanges 20.44M shares for pre-funded warrants; RA Capital voting capped at 33%
--------------------------------------------------------------------------------

- Exchanged 20,440,000 shares for pre-funded warrants with $0.0001 exercise price via Section 3(a)(9) exemption.
- Post-exchange shares outstanding: 47,744,435; RA Capital to own ~23% voting power.
- RA Capital and affiliates agree to vote any holdings above 33% proportionally with other stockholders.
- RA Capital may exchange additional shares for warrants with company's written consent.
- Pre-funded warrants are exercisable immediately and include a 33% beneficial ownership limitation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768446/000119312525315108/0001193125-25-315108-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768446/000119312525315108/d48098d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-315108

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer